Skip to content

Panchakarma procedure and ayurvedic medicine in the management of Eka Kushtha w.s.r. to Psoriasis

A comparative study to evaluate the efficacy of Neem Patra Lepa with and without Virechana in the management of Eka Kushtha w.s.r. to Psoriasis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100870
Enrollment
60
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

Dayanand Ayurvedic College and Hospital, Jalandhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling the diagnostic criteria of Eka Kushtha. 2. Patients of all varieties of Psoriasis will be selected. 3. Patient of either sex. 4.Patient between the age group of 16-60 years. 5.Both fresh and treated cases of Eka-Kushtha, which have already discontinued other treatments, will be selected. 6.Patients who are fit for Virechana Karma.

Exclusion criteria

Exclusion criteria: 1. Patient with other systemic disorders like uncontrolled Diabetes Mellitus type 2 and Hypertension, which interfere with the treatment. 2. Eka-Kushtha (Psoriasis) with extra cutaneous manifestations. 3. The patient has had chronicity for more than 15 years

Design outcomes

Primary

MeasureTime frame
1. Aswedanam (anhidrosis/ lack of sweating). 2. Mahavastu (broad-based) 3. Matshyashakalopamam (looks like the scales of a fish). 4. Krishana-arun varna (blackish red discoloration).Timepoint: Assessment of the patient will be done on day 1st, 16th, 30th and 45th

Secondary

MeasureTime frame
1. Auspitz Sign 2. Candle grease sign 3. PASI ScoreTimepoint: Assessment of the patient will be done on day 1st, 16th, 30th and 45th

Countries

India

Contacts

Public ContactDr Simran

Dayanand Ayurvedic College, Jalandhar

drparv1@gmail.com7589303536

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026